An open, randomised, parallel, three treatment groups, multicentre, phase IV study - in real life - to compare the change in social outcome of quetiapine fumarate (Seroquel) combined with cognitive remediation therapy to conventional treatment in patients with schizophrenia
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2011
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms SCORE
- Sponsors AstraZeneca
- 09 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 19 Oct 2006 New trial record.